Reporting owner · CIK 0001834021
Kirn David
SEC Form 4 history across 1 companies, 7 transactions and 3 filings.
SRSee Remarks4D Molecular Therapeutics, Inc.
Open-market transaction mix0% buys0 buys · 5 sales
Available history · Aug 19, 2026 – Oct 05, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | S · sale10b5-1 detectedSEC filing ↗ | -$3.70kView disclosure → | |
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | S · sale10b5-1 detectedSEC filing ↗ | -$750kView disclosure → | |
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | S · sale10b5-1 detectedSEC filing ↗ | -$811kView disclosure → | |
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | S · sale10b5-1 detectedSEC filing ↗ | -$425kView disclosure → | |
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | S · sale10b5-1 detectedSEC filing ↗ | -$662kView disclosure → | |
FDMT4D Molecular Therapeutics, Inc. | Kirn DavidSR | M · exercise10b5-1 detectedSEC filing ↗ | $207kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at 4D Molecular Therapeutics, Inc. on Oct 05, 2026 valued at $3,702.
Review SEC filingLatest buy
No open-market insider purchase is available.
Latest sale
sale at 4D Molecular Therapeutics, Inc. on Oct 05, 2026 valued at $3,702.
Review SEC filingMonthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 0 | 2 | $0.00 | $1,088,273.27 | -$1,088,273.27 |
| Sep 2026 | 0 | 1 | $0.00 | $811,003.70 | -$811,003.70 |
| Oct 2026 | 0 | 2 | $0.00 | $753,937.24 | -$753,937.24 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$530.6K
Median P/S size$662.6K
Direct7
Indirect0
Oct 05, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
6 observations · Aug 19, 2026 – Oct 5, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 5, 2026709,153 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 19, 2026 | 894,895 | Aug 21, 2026 | View transaction |
| Aug 19, 2026 | 851,746 | Aug 21, 2026 | View transaction |
| Aug 19, 2026 | 825,819 | Aug 21, 2026 | View transaction |
| Sep 14, 2026 | 767,486 | Sep 16, 2026 | View transaction |
| Oct 5, 2026 | 709,425 | Oct 7, 2026 | View transaction |
| Oct 5, 2026 | 709,153 | Oct 7, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Kirn David Insider Activity FAQ
SEC Form 4 context
Who is Kirn David?
Kirn David is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001834021.
Which companies has Kirn David reported transactions for?
4D Molecular Therapeutics, Inc.
When was Kirn David's latest insider buy?
No open-market insider purchase is available for this period.
When was Kirn David's latest insider sale?
sale at 4D Molecular Therapeutics, Inc. on Oct 05, 2026 valued at $3,702.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.